Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.

Dodd, Jodie M; McLeod, Anne; Windrim, Rory C; Kingdom, John

Dodd, Jodie M; McLeod, Anne; Windrim, Rory C; Kingdom, John.

Affiliation

Dodd JM; School of Paediatrics and Reproductive Health, Discipline of Obstetrics and Gynaecology, The University of Adelaide, Adelaide, Australia. jodie.dodd@adelaide.edu.au.

Cochrane Database Syst Rev ; (7): CD006780, 2013 Jul 24.

Article in En | MEDLINE | ID: mdl-23884904

Subject(s)

Fibrinolytic Agents/therapeutic use; Placenta Diseases/prevention & control; Thrombosis/prevention & control; Aspirin/therapeutic use; Dipyridamole/therapeutic use; Eclampsia/prevention & control; Female; Heparin/therapeutic use; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Pre-Eclampsia/drug therapy; Pre-Eclampsia/prevention & control; Pregnancy; Randomized Controlled Trials as Topic; Trapidil/therapeutic use; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Placenta Diseases / Thrombosis / Fibrinolytic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Infant / Newborn / Pregnancy Language: En Journal: Cochrane Database Syst Rev Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2013 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google